(Q38036105)

27 August 2017

title

Management of pregnancy in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

27 August 2017

0 references

0 references

2

Michelle Petri

1 reference

27 August 2017

Aisha Lateef

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

21 August 2012

1 reference

Nature Reviews Rheumatology

27 August 2017

published in

1 reference

27 August 2017

volume

8

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

710-718

1 reference

Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Decreased live births in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Stranger in a strange land

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Effect of pregnancy on serum cytokines in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Disassociation of sex hormone levels and cytokine production in SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

SLE and pregnancy: the potential role for regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

A national study of the complications of lupus in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The impact of increased lupus activity on obstetric outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Maternal and foetal outcomes in pregnant patients with active lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Early risk factors for pregnancy loss in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The Hopkins Lupus Pregnancy Center: ten key issues in management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Cutaneous lupus erythematosus during the neonatal and childhood periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Non-cardiac manifestations of neonatal lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Spectrum of cardiac involvement in neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Ro/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Diagnosing foetal atrioventricular heart blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Combined oral contraceptives in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

A trial of contraceptive methods in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pathogenic role of anti-beta2-glycoprotein I antibodies on human placenta: functional effects related to implantation and roles of heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Management of antiphospholipid syndrome in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Plasmapheresis and pregnancy outcome in patients with antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Anti-inflammatory and immunosuppressive drugs and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Hydroxychloroquine in lupus pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pregnancy outcome in women exposed to leflunomide before or during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Birth outcomes in women who have taken leflunomide during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Clopidogrel and pregnancy: a situation pregnant with danger?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Major congenital malformations after first-trimester exposure to ACE inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

ASH position paper: hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

High Levels of Maternal Serum IL-17 and Activin A in Pregnant Women Affected by Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prospective study of systemic lupus erythematosus pregnancies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Assessing disease activity in SLE patients during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Measuring systemic lupus erythematosus activity during pregnancy: validation of the lupus activity index in pregnancy scale

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Hopkins Lupus Pregnancy Center: 1987 to 1996

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Pregnancy Outcomes in Systemic Lupus Erythematosus with and without Previous Nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Antenatal screening for pre-eclampsia: evaluation of the NICE and pre-eclampsia community guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Thyroid disease in pregnant women with systemic lupus erythematosus: increased preterm delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Cardiac time intervals of normal fetuses using noninvasive fetal electrocardiography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

The use of bisphosphonates in women prior to or during pregnancy and lactation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2012.133

Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?

31 March 2020

1 reference

12 December 2020

Pregnancy outcomes in women with systemic lupus erythematosus

1 reference

12 December 2020

Beta-adrenergic receptor blockers. Adverse effects and drug interactions

1 reference

12 December 2020

Use of diuretics during pregnancy

1 reference

12 December 2020

Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience

1 reference

12 December 2020

Use of warfarin during pregnancy

1 reference

12 December 2020

Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus.

1 reference

12 December 2020

Drug-eluting stent implantation for acute myocardial infarction during pregnancy with use of glycoprotein IIb/IIIa inhibitor, aspirin and clopidogrel.

1 reference

12 December 2020

Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period

1 reference

12 December 2020

Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2012.133

1 reference

Dimensions Publication ID

27 August 2017

1032311911

0 references

1 reference